708 related articles for article (PubMed ID: 32631918)
1.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
2. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
3. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
Yu H; Hanes M; Chrisp CE; Boucher JC; Deretic V
Infect Immun; 1998 Jan; 66(1):280-8. PubMed ID: 9423869
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
[TBL] [Abstract][Full Text] [Related]
5. P. aeruginosa Biofilms in CF Infection.
Wagner VE; Iglewski BH
Clin Rev Allergy Immunol; 2008 Dec; 35(3):124-34. PubMed ID: 18509765
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
[TBL] [Abstract][Full Text] [Related]
7. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.
Boucher JC; Yu H; Mudd MH; Deretic V
Infect Immun; 1997 Sep; 65(9):3838-46. PubMed ID: 9284161
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells.
Tsuchiya M; Kumar P; Bhattacharyya S; Chattoraj S; Srivastava M; Pollard HB; Biswas R
J Interferon Cytokine Res; 2013 Mar; 33(3):121-9. PubMed ID: 23289731
[TBL] [Abstract][Full Text] [Related]
9. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
[No Abstract] [Full Text] [Related]
11. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
[TBL] [Abstract][Full Text] [Related]
12. Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of
Bielen K; 's Jongers B; Boddaert J; Raju TK; Lammens C; Malhotra-Kumar S; Jorens PG; Goossens H; Kumar-Singh S
Front Cell Infect Microbiol; 2017; 7():274. PubMed ID: 28680858
[TBL] [Abstract][Full Text] [Related]
13. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
Malhotra S; Hayes D; Wozniak DJ
J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
[TBL] [Abstract][Full Text] [Related]
14. Early IL-2 treatment of mice with Pseudomonas aeruginosa pneumonia induced PMN-dominating response and reduced lung pathology.
Calum HP; Moser C; Jensen PO; Bjarnsholt T; Givskov M; Høiby N
APMIS; 2020 Dec; 128(12):647-653. PubMed ID: 32794206
[TBL] [Abstract][Full Text] [Related]
15. Postnatal Ozone Exposure Disrupts Alveolar Development, Exaggerates Mucoinflammatory Responses, and Suppresses Bacterial Clearance in Developing
Choudhary I; Vo T; Paudel K; Yadav R; Mao Y; Patial S; Saini Y
J Immunol; 2021 Aug; 207(4):1165-1179. PubMed ID: 34330754
[TBL] [Abstract][Full Text] [Related]
16. Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in Muco-Obstructive Lung Disease.
Lewis BW; Sultana R; Sharma R; Noël A; Langohr I; Patial S; Penn AL; Saini Y
J Immunol; 2017 Aug; 199(3):1170-1183. PubMed ID: 28667160
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
Tucker SL; Sarr D; Rada B
BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.
Head NE; Yu H
Infect Immun; 2004 Jan; 72(1):133-44. PubMed ID: 14688090
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
